Bendell, J. C., Zakari, A., Peyton, J. D., Boccia, R., Moskowitz, M., Gian, V., . . . Meluch, A. (2016). A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only. Oncologist.
Citação norma ChicagoBendell, Johanna C., et al. "A Phase II Study of FOLFOXIRI Plus Panitumumab Followed By Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only." Oncologist 2016.
MLA CitationBendell, Johanna C., et al. "A Phase II Study of FOLFOXIRI Plus Panitumumab Followed By Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only." Oncologist 2016.